ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : ¾àǰ À¯Çüº°, ÀûÀÀÁõº°, ȯÀÚ±ºº°, ÃÖÁ¾ ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Inhalation And Nasal Spray Generic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Indication, By Patient Demographics, By End-use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1588718
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 160 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 490¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 8.56%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÅÁ¦Ç° Ãâ½Ã, ¸¸¼º È£Èí±â ÁúȯÀÇ È®»ê, ºñ¿ë È¿À²ÀûÀÎ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °í·É Àα¸ Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

ºñ¿ë È¿À²ÀûÀÎ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í Á¦³×¸¯ ÀǾàǰ »ç¿ë¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿øÀº ¿¹Ãø ±â°£ µ¿¾È ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ÀϺ» Á¤ºÎ´Â Àüü ÀǾàǰ ÁöÃâÀ» Á¶Á¤Çϱâ À§ÇØ Àú·ÅÇÑ Á¦³×¸¯ ÀǾàǰÀÇ »ç¿ëÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Áö³­ 10³â°£ Á¦³×¸¯ ÀǾàǰ »ç¿ëÀ» Àå·ÁÇÏ´Â ±ÔÁ¦¸¦ ½ÃÇàÇÔÀ¸·Î½á ´Þ¼ºµÇ¾ú½À´Ï´Ù.

Á¦¾à»çµéÀÇ È£Èí±â ºÐ¾ß ½Å¾à°³¹ß¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¶»ç¿Í ÈíÀÔ ¹× ºñ°­¿ë ÀǾàǰÀÇ Á¦³×¸¯ Á¦Ç° ½ÂÀÎÀº ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 3¿ù Cipla Inc.´Â ¹Ì±¹ FDA·ÎºÎÅÍ ÆíµÎÅë Ä¡·á¸¦ À§ÇÑ Imitrex Nasal SprayÀÇ Á¦³×¸¯ ÀǾàǰÀÎ Sumatriptan Nasal SprayÀÇ ANDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ¶ÇÇÑ, 2020³â 5¿ù¿¡´Â MigranalÀÇ Á¦³×¸¯ ÀǾàǰÀÎ Dihydroergotamine Mesylate Nasal SprayÀÇ ANDA ½ÂÀΰú ÇÔ²² FDA·ÎºÎÅÍ °æÀï Á¦³×¸¯ ÀǾàǰ(Competitive Generic Therapy) ÁöÁ¤À» ¹Þ¾Ò½À´Ï´Ù.

ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : ¾àÁ¦ Ŭ·¡½º ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : ÀûÀÀÁõ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : ȯÀÚ Àα¸Åë°è ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : À¯Åë ä³Î ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµº° Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦10Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Inhalation And Nasal Spray Generic Drugs Market Growth & Trends:

The global inhalation and nasal spray generic drugs market size is expected to reach USD 49.09 billion by 2030, registering a CAGR of 8.56% from 2025 to 2030, according to a new report by Grand View Research, Inc. New product launches, mounting prevalence of chronic respiratory diseases, growing demand for cost-effective medicines, and rising geriatric population are some of the major factors boosting the market growth.

Rising demand for cost-effective medicines and government support for the use of generics is expected to drive the demand for inhalation and nasal spray generic drugs over the forecast period. For instance, the Government of Japan has been promoting the usage of inexpensive generic drugs in order to regulate the overall pharmaceutical expenditure. This was accomplished through the execution of regulations to encourage the use of generic drugs in the past decade.

Rising number of M&A, partnerships, and collaborations among leading manufacturers including Teva Pharmaceuticals, Glenmark Specialty S.A., and Hikma Pharmaceuticals PLC is another major factor propelling the growth. For instance, in January 2022, Glenmark Specialty S.A., a Swiss subsidiary of Glenmark Pharmaceuticals Ltd., partnered with Lotus International Pte. Ltd. for marketing Ryaltris nasal spray in Vietnam, Hong Kong, and Singapore. Under this agreement, Glenmark Specialty S.A. will manufacture and supply Ryaltris, and Lotus International Pte. Ltd. will commercialize the product. Similarly, in February 2020, Glenmark Specialty signed a licensing agreement with Hikma Pharmaceuticals PLC to commercialize Ryaltrisin in the U.S.

Extensive research in the respiratory drug discovery and generic product approvals of inhalation and nasal drugs by pharmaceutical companies are projected to fuel growth. For instance, in March 2021, Cipla Inc. received ANDA approval from the U.S. FDA for Sumatriptan Nasal Spray, a generic equivalent of Imitrex Nasal Spray indicated for migraine treatment. In addition, in May 2020, the company received Competitive Generic Therapy designation from FDA along with ANDA approval for Dihydroergotamine Mesylate Nasal Spray, a generic version of Migranal.

Inhalation And Nasal Spray Generic Drugs Market Report Highlights:

Table Of Contents

Chapter 1. Methodology And Scope

Chapter 2. Executive Summary

Chapter 3. Inhalation And Nasal Spray Generic Drugs Market Variables, Trends & Scope

Chapter 4. Inhalation And Nasal Spray Generic Drugs Market: Drug Class Estimates & Trend Analysis

Chapter 5. Inhalation And Nasal Spray Generic Drugs Market: Indication Estimates & Trend Analysis

Chapter 6. Inhalation And Nasal Spray Generic Drugs Market: Patient Demographics Estimates & Trend Analysis

Chapter 7. Inhalation And Nasal Spray Generic Drugs Market: End Use Estimates & Trend Analysis

Chapter 8. Inhalation And Nasal Spray Generic Drugs Market: Distribution Channel Estimates & Trend Analysis

Chapter 9. Inhalation And Nasal Spray Generic Drugs Market: Regional Estimates & Trend Analysis By Product, Application, And End Use

Chapter 10. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â